Lo pronostic del càncer del palmon depend de diferents factors, coma l'estadi del càncer, lo tipe de càncer del palmon, e l'estat general de santat del pacient.
Lo càncer de palmon de cellulas non pichonas, qu'es lo tipe mai comun, a un taus de subrevida de 5 ans de 18% per totes los estadis combinats.
Mas, se lo càncer es detectat d'ora, lo taus de subrevida a 5 ans pòt èsser fins a 57%.
Es important de notar qu'aquestas son d'estatisticas generalas e los resultats individuals pòdon variar.
Las opcions de tractament e los progrèsses de la medecina contunhan a melhorar, e fòrça pacients pòdon viure mai longtemps e amb una melhora qualitat de vida amb los suènhs e la gestion apropriats.
Martini B: [Lung cancer--epidemiology, prognosis and therapy]. Med Monatsschr Pharm. 2006, 29 (6): 217-21.
Zou T, Liu JY, She L, Yin JY, Li X, Li XP, Zhou HH, Chen J, Liu ZQ: The Association Between Heat-Shock Protein Polymorphisms and Prognosis in Lung Cancer Patients Treated With Platinum-Based Chemotherapy. Front Pharmacol. 2020, 11 (): 1029.
Li L, Zhou Q, Luo D, Xu Y, Yang H, Zhang S, Li A, Li H, Lv C: [A study on the relationship between lung cancer cell apoptosis and prognosis in patients with human non-small cell lung cancer.]. Zhongguo Fei Ai Za Zhi. 1998, 1 (2): 70-3.
Feng YY, Yang Y, Wang YY, Bai XX, Hai P, Zhao R: [Hypomethylation of DAPL1 associated with prognosis of lung cancer patients with EGFR Del19 mutation]. Zhonghua Zhong Liu Za Zhi. 2021, 43 (12): 1264-1268.
Xiao Y, Zhu S, Yin W, Liu X, Hu Y: IGFBP-4 expression is adversely associated with lung cancer prognosis. Oncol Lett. 2017, 14 (6): 6876-6880.
Lang J, Zhao Q, He Y, Yu X: Bone turnover markers and novel biomarkers in lung cancer bone metastases. Biomarkers. 2018, 23 (6): 518-526.
['Disclaimer: medecina']
['Aqueste site internet es porgit sonque per tòca educativa e informativa e constituís pas un conselh medical o de servici professional.']
['Las informacions donadas se devon pas utilizar per diagnosticar o tractar un problèma de santat o malautiá, e los que cercan un conselh medical personal se devon consultar amb un mètge autorizat.']
["Notatz que lo malhum neuronal que genèra las responsas a las questions, es subretot inexacte al subjècte del contengut numeric. Per exemple, lo nombre de personas diagnosticadas d'una malautiá especifica."]
["Sempre demandar lo conselh de vòstre mètge o d'un autre provesidor de santat qualificat al subjècte d'una condicion medicala. Jamai non pas considerar los conselhs professionals o lo retard per los cercar a causa de quicòm qu'avètz legit sus aqueste site."]
["Disclaimer: Drech d'autor"]
["Lo Digital Millennium Copyright Act de 1998, 17 U.S.C. § 512 (lo DMCA) prevei de recors pels proprietaris dels dreches d'autor que creson que lo material qu'apareis sus Internet infringe lors dreches segon la lei dels dreches d'autor dels EUA. "]
["Se cresètz de bona fe que quin contengut que siá o quin material que siá mes a dispausicion en relacion amb nòstre sit web o nòstres servicis infringe vòstre drech d'autor, vos (o vòstre agent) podètz nos mandar un avertiment demandant que lo contengut o material siá levat, o que l'accès li siá blocat."]
['Los anoncis se devon mandar per escrich per corrièr electronic (vejatz la seccion "Contacte" per l\'adreça).']
["La DMCA exigís que vòstre avís sus la violacion de copyright inclusís las informacions seguentas: (1) descripcion de l'òbra protegida qu'es l'objècte de la violacion; (2) descripcion del contengut sus que se pretend la violacion e informacion sufisenta per nos permetre de localizar lo contengut; (3) vòstras informacions de contacte, coma vòstra adreça, numèro de telefòn e adreça e-mail; (4) una declaracion que cresètz de bona fe que lo contengut de la mena que se reclama es pas autorizat pel proprietari del copyright, o son agent, o per l'aplicacion de quina lei que siá; "]
["5) una declaracion signada per vos, jos pena de perjure, que las informacions contengudas dins la notificacion son precisas e qu'avètz l'autoritat per far valer los dreches d'autor que se pretendon èsser violats;"]
["e (6) una signatura fisica o electronica del proprietari del copyright o d'una persona autorizada a agir al nom del proprietari. "]
["Lo manca d'inclure totas las informacions çai sus pòt provocar un retard dins lo tractament de vòstra reclamacion."]
['Contacte']
['Mandatz-nos un email amb vòstras questions / suggestions.']
What is prognosis of lung cancer?
The prognosis of lung cancer depends on several factors, including the stage of the cancer, the type of lung cancer, and the overall health of the patient.
Non-small cell lung cancer, which is the most common type, has a 5-year survival rate of about 18% for all stages combined.
However, if the cancer is caught early, the 5-year survival rate can be as high as 57%. Small cell lung cancer, which is less common, has a 5-year survival rate of about 7% for all stages combined.
It is important to note that these are general statistics and individual outcomes may vary.
Treatment options and advancements in medicine continue to improve, and many patients can live longer and have a better quality of life with proper care and management.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
["A l'entorn de"]
["BioMedLib utiliza d'ordinators automatics (algoritmes d'aprendissatge automatic) per generar de parelhs de questions e responsas."]
['Començam amb 35 milions de publicacions biomedicalas de PubMed/Medline. Tanben, paginas web de RefinedWeb.']
